Literature DB >> 17076268

Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.

N Muge Kuyumcu-Martinez1, Thomas A Cooper.   

Abstract

Myotonic dystrophy (DM), the most common form of adult onset muscular dystrophy, affects skeletal muscle, heart, and the central nervous system (CNS). Mortality results primarily from muscle wasting and cardiac arrhythmias. There are two forms of the disease: DM1 and DM2. DM1, which constitutes 98% of cases, is caused by a CTG expansion in the 3' untranslated region (UTR) of the DMPK gene. DM2 is caused by a CCTG expansion in the first intron of the ZNF9 gene. RNA containing CUG- or CCUG-expanded repeats are transcribed but are retained in the nucleus in foci. Disease pathogenesis results primarily from a gain of function of the expanded RNAs, which alter developmentally regulated alternative splicing as well as pathways of muscle differentiation. The toxic RNA has been implicated in sequestration of splicing regulators and transcription factors thereby causing specific symptoms of the disease. Here we review the proposed mechanisms for the toxic effects of the expanded repeats and discuss the molecular mechanisms of splicing misregulation and disease pathogenesis.

Entities:  

Mesh:

Year:  2006        PMID: 17076268      PMCID: PMC4127983          DOI: 10.1007/978-3-540-34449-0_7

Source DB:  PubMed          Journal:  Prog Mol Subcell Biol        ISSN: 0079-6484


  163 in total

1.  Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts.

Authors:  P S Sarkar; B Appukuttan; J Han; Y Ito; C Ai; W Tsai; Y Chai; J T Stout; S Reddy
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

2.  Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.

Authors:  R S Savkur; A V Philips; T A Cooper
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

3.  Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.

Authors:  J W Miller; C R Urbinati; P Teng-Umnuay; M G Stenberg; B J Byrne; C A Thornton; M S Swanson
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

4.  Divergent mitochondrial and endoplasmic reticulum association of DMPK splice isoforms depends on unique sequence arrangements in tail anchors.

Authors:  René E M A van Herpen; Ralph J A Oude Ophuis; Mietske Wijers; Miranda B Bennink; Fons A J van de Loo; Jack Fransen; Bé Wieringa; Derick G Wansink
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

5.  Cis and trans effects of the myotonic dystrophy (DM) mutation in a cell culture model.

Authors:  J D Amack; A P Paguio; M S Mahadevan
Journal:  Hum Mol Genet       Date:  1999-10       Impact factor: 6.150

6.  Identification of a novel alternative splicing isoform of human amyloid precursor protein gene, APP639.

Authors:  Ke Tang; Chen Wang; Chengyong Shen; Shuli Sheng; Rivka Ravid; Naihe Jing
Journal:  Eur J Neurosci       Date:  2003-07       Impact factor: 3.386

7.  Somatic instability of CTG repeat in myotonic dystrophy.

Authors:  T Ashizawa; J R Dubel; Y Harati
Journal:  Neurology       Date:  1993-12       Impact factor: 9.910

Review 8.  Myotonia caused by mutations in the muscle chloride channel gene CLCN1.

Authors:  Michael Pusch
Journal:  Hum Mutat       Date:  2002-04       Impact factor: 4.878

9.  Mutant DMPK 3'-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD.

Authors:  Jeffrey D Amack; Shannon R Reagan; Mani S Mahadevan
Journal:  J Cell Biol       Date:  2002-11-11       Impact factor: 10.539

10.  Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues.

Authors:  K L Taneja; M McCurrach; M Schalling; D Housman; R H Singer
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

View more
  36 in total

1.  Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2.

Authors:  Rosanna Cardani; Marzia Giagnacovo; Annalisa Botta; Fabrizio Rinaldi; Alessandra Morgante; Bjarne Udd; Olayinka Raheem; Sini Penttilä; Tiina Suominen; Laura V Renna; Valeria Sansone; Enrico Bugiardini; Giuseppe Novelli; Giovanni Meola
Journal:  J Neurol       Date:  2012-03-10       Impact factor: 4.849

2.  Tau as a biomarker of neurodegenerative diseases.

Authors:  Susanna Schraen-Maschke; Nicolas Sergeant; Claire-Marie Dhaenens; Stéphanie Bombois; Vincent Deramecourt; Marie-Laure Caillet-Boudin; Florence Pasquier; Claude-Alain Maurage; Bernard Sablonnière; Eugeen Vanmechelen; Luc Buée
Journal:  Biomark Med       Date:  2008-08       Impact factor: 2.851

Review 3.  Repeat-associated RNA structure and aberrant splicing.

Authors:  Melissa A Hale; Nicholas E Johnson; J Andrew Berglund
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2019-07-16       Impact factor: 4.490

4.  PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1.

Authors:  Guey-Shin Wang; Muge N Kuyumcu-Martinez; Satyam Sarma; Nitin Mathur; Xander H T Wehrens; Thomas A Cooper
Journal:  J Clin Invest       Date:  2009-11-09       Impact factor: 14.808

5.  Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy.

Authors:  Guey-Shin Wang; Debra L Kearney; Mariella De Biasi; George Taffet; Thomas A Cooper
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

6.  Genomic features of the human dopamine transporter gene and its potential epigenetic States: implications for phenotypic diversity.

Authors:  Elena Shumay; Joanna S Fowler; Nora D Volkow
Journal:  PLoS One       Date:  2010-06-10       Impact factor: 3.240

7.  Global regulation of alternative splicing during myogenic differentiation.

Authors:  Christopher S Bland; Eric T Wang; Anthony Vu; Marjorie P David; John C Castle; Jason M Johnson; Christopher B Burge; Thomas A Cooper
Journal:  Nucleic Acids Res       Date:  2010-07-15       Impact factor: 16.971

8.  HTS-Compatible Patient-Derived Cell-Based Assay to Identify Small Molecule Modulators of Aberrant Splicing in Myotonic Dystrophy Type 1.

Authors:  Debra A O'Leary; Leonardo Vargas; Orzala Sharif; Michael E Garcia; Yury J Sigal; Siu-Kei Chow; Christian Schmedt; Jeremy S Caldwell; Achim Brinker; Ingo H Engels
Journal:  Curr Chem Genomics       Date:  2010-03-19

Review 9.  Diverse molecular functions of Hu proteins.

Authors:  M N Hinman; H Lou
Journal:  Cell Mol Life Sci       Date:  2008-10       Impact factor: 9.261

10.  The Alternative Splicing Factor, MBNL1, Inhibits Glioblastoma Tumor Initiation and Progression by Reducing Hypoxia-Induced Stemness.

Authors:  Dillon M Voss; Anthony Sloan; Raffaella Spina; Heather M Ames; Eli E Bar
Journal:  Cancer Res       Date:  2020-09-14       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.